Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
批准号:
7492844
负责人:
THOMAS DOETSCHMAN
金额:
$35.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2011-02-28
关键词:
Acquired Immunodeficiency SyndromeAddressAdoptive TransferAffectAntigensApoptosisArthritisAttenuatedAutoantigensAutoimmune DiseasesAutoimmune ProcessCalcineurinCalciumCancer VaccinesCell physiologyCellsCessation of lifeConditionContractsCultured CellsDependencyDevelopmentDiseaseDominant-Negative MutationEffector CellExhibitsGenerationsHandHomeostasisImmune ToleranceImmune systemIn VitroInflammationInflammatoryInsulin-Dependent Diabetes MellitusKnock-outLigandsLymphocyteLymphocyte ActivationMADH3 geneMaintenanceMature T-LymphocyteMediatingMolecularMultiple SclerosisMusNatureNeoadjuvant TherapyNewborn InfantOvalbuminOvumPathway interactionsPeptidesPeripheralPlayPopulationPreventionProcessProductionRegulationResearch PersonnelRoleSelf ToleranceSignal PathwaySignal TransductionT cell regulationT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTransforming Growth Factor betaTransforming Growth FactorsTransgenic MiceTransgenic OrganismsTransplantationUpper armViralVirus Diseasesautocrinecell typecytokinehuman diseasein vivoleukemiaparacrinepathogenpreventprogramsreceptorresponsesizethymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: T-cell homeostasis is an essential process for maintaining peripheral lymphocyte pool
size. T cells must provide a diverse repertoire of antigen recognition to effectively recognize and destroy
pathogens that they encounter. Antigen-specific T-cell pools are expanded during viral infection and are
contracted after the initial viral clearance to make space for the entire T-cell repertoire. This is a tightly
regulated process since the space available for lymphocytes is limited. Transforming Growth Factor (3
signaling is required to prevent autoimmune disease and dysregulation of T-cell homeostasis. Normally, T
cells must interact with self-MHC molecules for their survival, maintenance and homeostatic expansion, but
under some pathological conditions such interactions cause inappropriate activation of T cells leading to
autoimmune disease. Characterization of TGF01-deficient mice has revealed that their autoimmune disease
results from spontaneous activation of their T cells in response to self-antigen recognition by having an
inappropriately low threshold level of activation through a Calcium-Calcineurin signaling cascade. Elimination
of T cells or their self-antigen recognition is sufficient to prevent autoimmune disease in these mice, and
reducing calcineurin signaling drastically attenuates their autoimmune disease. In addition, it is known that
without TGF(3 signaling there are less T-regulatory cells, the cells that mediate immune tolerance. Here we
propose to investigate mechanisms and processes underlying the role of TGFp in the regulation of T-cell
homeostasis and self-tolerance. Firstly, we will address how TGF01 regulates T-cell pool size using an
Ovalbumin-specific T-cell receptor transgenic TGF(31-deficientmouse strain. Adoptive transfer and
Ovalbumin activation studies will be used. Secondly, we will study the role of TGF(31 and its signaling
pathways in peripheral T-cell regulation. T-regulatory cell transfer to effect tolerizing activity will beperformed
and the passive or infectious nature of that activity will be determined.
Relevance: Dysregulation of homeostatic process has been implicated in many human diseases such as
AIDS, leukemia, inflammatory bowl disease, and autoimmune diseases such as type 1 diabetes, multiple
sclerosis and arthritis. Processes involved in T-cell homeostasis such as lymphocyte activation, survival and
death are presently under intensive study because of their relevance to these diseases. The information
gained from these studies will be useful for developing therapies for the induction of tolerance during
transplantation, for enhancing tumor vaccine potential, and for the prevention of autoimmune disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-specific analysis of transcription and epigenomic status in PDAC
-
批准号:8468670
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2012
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Cell-specific analysis of transcription and epigenomic status in PDAC
-
批准号:8227178
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2012
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Experimental Mice
-
批准号:7944527
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2009
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7197991
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7023314
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7759458
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7775091
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6623478
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6729931
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6466184
-
项目类别:
-
资助金额:$37.94万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6579909
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6579908
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6865395
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6617326
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6618908
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6617327
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6618907
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
CORE--MOUSE FACILITY
-
批准号:6346153
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
TUMOR SUPPRESSOR HETEROZYGOTES AS GENOTOXICANT REPORTERS
-
批准号:6346150
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
ANIMAL MODELS FOR CARDIOVASCULAR DISEASE
-
批准号:6202280
-
项目类别:
-
资助金额:$20.67万
-
财政年份:1999
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
海外基金